Yüklüyor......
Bayesian designs to account for patient heterogeneity in phase II clinical trials
PURPOSE OF REVIEW: Between-patient heterogeneity is very common in clinical trials. This complicates treatment evaluation, due to known prognostic subgroup effects or potential treatment-subgroup interactions. We review two Bayesian phase II clinical trial designs that account explicitly for patient...
Kaydedildi:
| Yayımlandı: | Curr Opin Oncol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2008
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5555403/ https://ncbi.nlm.nih.gov/pubmed/18525336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0b013e328302163c |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|